Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    1.0%
    Check dated 2024-12-14T22:39:54.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    4%
    Check dated 2024-12-07T16:13:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-11-30T13:04:30.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    New features have been added to the website, while several options related to participant groups, interventions, and data download formats have been removed.
    Difference
    6%
    Check dated 2024-11-23T04:34:14.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Several key health-related resources, including links to MedlinePlus and various rare disease pages, have been removed from the website.
    Difference
    0.7%
    Check dated 2024-11-15T23:41:15.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with new resources added related to lymphoma and treatments, including links to MedlinePlus and various rare disease information pages.
    Difference
    7%
    Check dated 2024-11-08T18:15:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.